Portfolio company
Callyope
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Callyope develops an AI platform that monitors patient speech and sensor data to help psychiatrists assess and manage mental health symptoms remotely.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Thymia
This company develops artificial intelligence software to objectively assess and monitor mental health conditions for healthcare providers and corporate wellness platforms.
Psyrin
This company develops voice biomarker technology and intake software to automate psychiatric assessments and documentation for mental health clinics and researchers.
CareLoop Health
This company provides a digital monitoring and relapse prevention platform for healthcare professionals treating patients with severe mental illness and psychosis.
Behavidence
This company develops a digital platform that uses passive smartphone monitoring to provide mental health metrics for clinicians, insurers and government agencies.
PsyScale
This company develops clinical AI software to provide structured treatment for anxiety and depression for commissioners, healthcare providers and insurers.
Ascenda
This company provides an artificial intelligence platform for psychologists and employers to monitor patient mental health and psychosocial risk between clinical therapy sessions.
Carelog
This company develops an artificial intelligence assistant that transcribes patient conversations and generates structured clinical documentation for therapists, psychologists and healthcare professionals.
DecipHER
This company develops a diagnostic platform combining artificial intelligence and biological markers to identify maternal mental health risks for pregnant women and new mothers.
